SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-037862
Filing Date
2020-08-06
Accepted
2020-08-06 16:53:56
Documents
60
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 XENE-10Q-20200806-Q2 xene-10q_20200630.htm   iXBRL 10-Q 2416882
2 EX-10.2 xene-ex102_140.htm EX-10.2 42766
3 EX-31.1 xene-ex311_9.htm EX-31.1 18868
4 EX-31.2 xene-ex312_7.htm EX-31.2 18931
5 EX-32.1 xene-ex321_6.htm EX-32.1 11555
6 EX-32.2 xene-ex322_8.htm EX-32.2 11192
  Complete submission text file 0001564590-20-037862.txt   6603547

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA xene-20200630.xsd EX-101.SCH 42778
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE xene-20200630_cal.xml EX-101.CAL 44431
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE xene-20200630_def.xml EX-101.DEF 105764
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE xene-20200630_lab.xml EX-101.LAB 313320
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE xene-20200630_pre.xml EX-101.PRE 227761
12 EXTRACTED XBRL INSTANCE DOCUMENT xene-10q_20200630_htm.xml XML 957766
Mailing Address 200 - 3650 GILMORE WAY BURNABY A1 V5G 48W
Business Address 200 - 3650 GILMORE WAY BURNABY A1 V5G 48W (604) 484-3300
Xenon Pharmaceuticals Inc. (Filer) CIK: 0001582313 (see all company filings)

IRS No.: 980661854 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36687 | Film No.: 201082470
SIC: 2834 Pharmaceutical Preparations